Oncolytics Biotech (NASDAQ:ONCY) Rating Reiterated by HC Wainwright
Oncolytics Biotech (NASDAQ:ONCY – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a note issued to investors...
Inari Medical (NASDAQ:NARI) Earns Hold Rating from Analysts at Stifel Nicolaus
Stifel Nicolaus initiated coverage on shares of Inari Medical (NASDAQ:NARI – Free Report) in a research report released on Tuesday morning, Marketbeat.com reports. The firm...
Recon Technology (NASDAQ:RCON) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Recon Technology (NASDAQ:RCON – Free Report) in a research report report published on Wednesday. The firm issued a sell...
StockNews.com Begins Coverage on Signature Bank (NASDAQ:SBNY)
StockNews.com started coverage on shares of Signature Bank (NASDAQ:SBNY – Free Report) in a research report report published on Wednesday morning. The brokerage issued a...
The Goldman Sachs Group Lowers Sirius XM (NASDAQ:SIRI) Price Target to $26.00
Sirius XM (NASDAQ:SIRI – Free Report) had its price target decreased by The Goldman Sachs Group from $32.50 to $26.00 in a research note released...
CrowdStrike (NASDAQ:CRWD) Rating Reiterated by Rosenblatt Securities
CrowdStrike (NASDAQ:CRWD – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Rosenblatt Securities in a report issued on Thursday, Benzinga reports....